WallStSmart
OGEN

Oragenics Inc

NYSE MKT: OGEN · HEALTHCARE · BIOTECHNOLOGY

$0.60
-1.21% today

Updated 2026-04-29

Market cap
$2.62M
P/E ratio
P/S ratio
89.28x
EPS (TTM)
$-4.56
Dividend yield
52W range
$1 – $10
Volume
0.3M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$2.00
+230.96%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.84M
- Revenue declining -91.30% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$131521.00$37653.00$0.00$0.00$0.00
Net income$-14.29M$-20.66M$-10.57M$-9.84M$-2.29M
EPS$-4.56
Free cash flow$-15.36M$-8.29M$-8.60M$-9.25B$-2.84M
Profit margin-10,863.96%-54,858.14%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
OGEN$2.62M243.73.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Oragenics Inc trades at $0.60. Our Smart Value Score of 24/100 indicates the stock is weak.

Frequently asked questions

What is Oragenics Inc's stock price?
Oragenics Inc (OGEN) trades at $0.60.
Is Oragenics Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Oragenics Inc (OGEN)?
The analyst target price is $2.00, representing +231.0% upside from the current price of $0.60.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD

Quick metrics

P/S ratio89.28x
ROE-243.90%
Beta1.21
50D MA$0.71
200D MA$0.99
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years